Ryman Community News

Ryman Prize

World-leading geriatrician and anti-ageism campaigner wins the Ryman Prize

Written by Ryman Prize Foundation
on December 15, 2021

MEDIA RELEASE December 15, 2021

Prime Minister Jacinda Ardern reveals Professor Kenneth Rockwood is the seventh winner of international health prize

Geriatrician, researcher, academic and anti-ageism campaigner Professor Kenneth Rockwood has won the 2021 Ryman Prize.

The award recognises Professor Rockwood’s more than 30 years of research, collaboration and practical clinical work for older adults living with frailty and dementia and his long-term campaign to battle ageism in healthcare.

Professor Rockwood’s win was announced by the Right Honourable Jacinda Ardern, Prime Minister of New Zealand.

IMG_7825_adj-for-webRyman Group Chief Executive Richard Umbers and Prime Minister Jacinda Ardern

The Ryman Prize is an annual $250,000 international award for the best work carried out anywhere in the world that has enhanced quality of life for older people. It is the richest prize of its kind in the world.

The prize has been awarded seven times and the winner is normally presented with the medal in person – but the COVID-19 pandemic meant Professor Rockwood could not travel to New Zealand to collect his prize and medal.

Professor Rockwood said the pandemic meant the health of older people was more important than ever.

“This is a fantastic recognition and the timing could not be better. It will give momentum and recognition to do a whole lot more research and work for a greater good.’’

The Ryman Prize attracts a world-class field of entrants each year. Each winner is chosen by an international jury of experts from across many disciplines.

Professor Rockwood was singled out for this year’s prize for a truly unique contribution to the understanding of ageing, Ryman Prize Director David King said.

“Professor Rockwood is a truly outstanding clinician and academic who has spent many decades combining his practical experience with a research basis to try and truly understand the causes of ageing. His Clinical Frailty Scale is used internationally, and he has made a massive contribution to scientific literature with hundreds of peer reviewed articles and contributions in the world’s leading medical research journals.

“One of his greatest contributions has been to combat ageism. His work has helped debunk common misconceptions that complex problems faced by older people – such as delirium, cognitive issues and frailty – were part of normal decline and that treatment options were limited.

“His other great contribution has been as a teacher and a clinical leader, inspiring talented specialists to join the field. As a result of his inspiration the work of a whole new generation of Ken Rockwoods is likely to benefit older people around the world in the years to come.’’

“Without a doubt he is made an enormous contribution to the health and care of older people, and he thoroughly deserves our gratitude.’’

 

 

About Kenneth Rockwood:

Kenneth Rockwood lives in Halifax, Nova Scotia, Canada. He is Professor of Geriatric Medicine and Neurology and the Kathryn Allen Weldon Professor of Alzheimer Research at Dalhousie University in Halifax. He is Senior Director of a newly formed Frailty and Elder Care Network at Nova Scotia Health and is an Honorary Professor of Population Science and Experimental Medicine, University College, London.

About the Ryman Prize:

The Ryman Prize is administered by the Ryman Foundation. The annual prize consists of a $250,000 grant which is awarded by an international jury to the best invention, idea, research concept or initiative that has enhanced quality of life for older people.

It is the world’s richest prize of its type and was established to create the equivalent of a Nobel Prize for people working in the field of the health of older people.

The prize was launched in 2015 and has been awarded seven times.

The inaugural prize was won by Gabi Hollows, the founding director of The Fred Hollows Foundation. Gabi Hollows set up the charity with her late husband Professor Fred Hollows, and together they worked tirelessly to tackle the problem of preventable blindness in older people in the developing world.

The 2016 Ryman Prize was won by Professor Henry Brodaty. Professor Brodaty is a pioneer in diagnosis and treatment of Alzheimer’s and dementia.

The 2017 Ryman Prize was won by Professor Peter St George-Hyslop, a geneticist and researcher based at Cambridge and the University of Toronto. Peter spent 30 years researching neuro-degenerative diseases, focusing on discovering the key genes and proteins that cause cells to degenerate.

Japanese inventor and technologist Professor Takanori Shibata won the 2018 Ryman Prize for his tenacity in pursing new technology to help ease the burden of older people suffering from dementia.

The 2019 Ryman Prize was won by Canadian neurosurgeon Dr Michael Fehlings. Dr Fehlings won the prize for his pioneering work for older people suffering from Degenerative Cervical Myelopathy (DCM), a degenerative neck compression problem which is the most common form of injury to the spinal cord.

Finnish academic and researcher Professor Miia Kivipelto won the 2020 Ryman Prize. The award recognised Professor Kivipelto’s more than 20 years of research into the prevention, diagnosis and treatment of cognitive impairment, Alzheimer’s Disease and dementia.

The Ryman Prize jury consists of:

  • Professor Brian Draper, Conjoint Professor in the School of Psychiatry at the University of New South Wales.
  • Professor Sarah Harper CBE, Director and Clore Professor of Gerontology at the Oxford Institute of Population Ageing.
  • Professor Tim Wilkinson, consulting geriatrician and Associate Dean of Medical Education, Otago School of Medicine.
  • Dr Naoko Muramatsu, health and ageing research specialist, University of Illinois at Chicago.
  • Professor Erwin Neher, Nobel Laureate and Director and Scientific Member at the Max Planck Institute for Biophysical Chemistry, University of Göttingen, Germany. Dr Neher is a biophysicist who won the Nobel Prize for Medicine in 1991.
  • Dr David Kerr, Ryman Healthcare Chairman, Fellow and Past President of the New Zealand Medical Association, Fellow with Distinction of the Royal New Zealand College of General Practitioners.

Media advisory: For interviews with Kenneth Rockwood or further information please contact Ryman Prize director David King on 03 366 4069 (00643 3664069) or 021 499 602 (006421 499 6902) david.king@rymanhealthcare.com.

About Ryman Healthcare:

Ryman was founded in 1984 and has become one of New Zealand’s largest listed companies. The company owns and operates 45 retirement villages in New Zealand and Australia which are home to more than 13,200 residents and the company employs 6,700 team members.

Media advisory: For further information, photos, interviews or comment please contact Corporate Affairs Manager David King on 03 366 4069 or 021 499 602 or Communications Advisor Maryvonne Gray on 027 552 0767.

You may also like:

Entries open for the 2022 Ryman Prize

MEDIA RELEASE 

"Being frail is not a disease."

2021 Ryman Prize winner Kenneth Rockwood interviewed on RNZ